These treatments target hormones that regulate appetite, metabolism, and insulin
Besides, two nitroimidazoles (Koike et al., 2020), itraconazole (Xu et al., 2021), and dichloroacetate (Sun et al., 2021) are also proven to have therapeutic potential through promoting ferroptosis in CSCs
Maquart, F., Bellon, G., Chaqour, B., Wegrowski, J., Patt, L., Trachy, R., Monboisse, J., Chastang, F., Birembaut, P., & Gillery, P
For type 1 diabetes, Semglee is used together with a short-acting insulin given before meals
Activation of the GLP-1 receptor by a non-peptidic agonist
Lets look closer at two of those: changes in hormones (think menopause) and popular medications like GLP-1s (such as semaglutide or tirzepatide)